Human Her2/ErbB2 Domain 4 Protein (HER-HM404)
KACTUS Biosystems Human Her2/ErbB2 Domain 4 Protein (HER-HM404) (catalog No. HER-HM404) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Pro489-Cys630.
KACTUS Biosystems Human Her2/ErbB2 Domain 4 Protein (HER-HM404) (catalog No. HER-HM404) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Pro489-Cys630.
KACTUS Biosystems Biotinylated Human Her2/ErbB2 Domain 4 Protein (HER-HM404B) (catalog No. HER-HM404B) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Pro489-Cys630.
Abclonal HER2/ErbB2 Rabbit mAb (Catalog Number: A21248) encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot...
NEU; NGL; HER2; TKR1; CD340; HER-2; VSCN2; MLN 19; MLN-19; c-ERB2; c-ERB-2; HER-2/neu; p185(erbB2)
NEU; NGL; HER2; TKR1; CD340; HER-2; VSCN2; MLN 19; MLN-19; c-ERB2; c-ERB-2; HER-2/neu; p185(erbB2)
Abclonal ABflo® 488 Rabbit anti-Human HER2/ErbB2 mAb (Catalog Number: A23182) encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own...
Abclonal ABflo® 647 Rabbit anti-Human HER2/ErbB2 mAb (Catalog Number: A23183) encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases.
Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only...
Bevacizumab Biosimilar, N297A Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human...